Molecular Imaging: Page 286

The election and radiology; Facebook faux pas; International Day of Radiology

November 7, 2012

Road to RSNA 2012: Molecular Imaging Preview

By Wayne Forrest

For molecular imaging, PET/MRI undoubtedly will garner considerable attention at the 2012 RSNA meeting in Chicago, as the hybrid modality gains interest with each new study that exalts its clinical potential. Preview the noteworthy molecular imaging and nuclear medicine scientific papers that will cover a wide range of clinical applications which will evaluate and benefit patient outcomes.

November 7, 2012

Road to RSNA 2012: Molecular Imaging Preview

FDG-PET and MRI could find keys to Alzheimer's

By Wayne Forrest

Thursday, November 29 | 11:30 a.m.-11:40 a.m. | SSQ14-07 | Room S504CDIn this study, researchers from the University of Washington used MRI, including diffusion-tensor imaging, and FDG-PET to discover different correlations across imaging biomarkers and brain regions in patients with cognitive impairment.

November 7, 2012

PET/MRI tops PET/CT in abdominopelvic lesion conspicuity

By Wayne Forrest

Wednesday, November 28 | 11:50 a.m.-12:00 p.m. | SSK08-09 | Room S504CDPET/MRI with ultrafast gradient-recalled echo and spin-echo sequences is superior to PET/CT for lesion conspicuity, thus potentially improving therapy for patients with abdominopelvic cancer, according to a study by Swiss researchers.

November 7, 2012

FDG-PET/CT helps assess pancreatic cancer recurrence

By Wayne Forrest

Wednesday, November 28 | 11:30 a.m.-11:40 a.m. | SSK13-07 | Room S505ABFDG-PET/CT has "excellent accuracy" in detecting a recurrence following resection of pancreatic cancer, and maximum standardized uptake values can be used in determining the prognosis of these patients, according to researchers from India.

November 7, 2012

FDG-PET/CT plays key role in treatment outcomes of prostate cancer

By Wayne Forrest

Wednesday, November 28 | 11:00 a.m.-11:10 a.m. | SSK13-04 | Room S505ABA preliminary study by researchers at the University of Southern California suggests that FDG-PET/CT provides unique prognostic information on outcomes for men with castrate-sensitive metastatic prostate cancer who are undergoing various forms of hormonal treatment.

November 7, 2012

Virtual FDG-PET/CT software shows hard-to-find malignancies

By Wayne Forrest

Wednesday, November 28 | 10:30 a.m.-10:40 a.m. | SSK13-01 | Room S505ABResearchers from the University of Düsseldorf in Germany have developed virtual FDG-PET/CT panendoscopy software for the upper airways that they say can detect pharyngeal and laryngeal malignancies.

November 7, 2012

DOTATATE-PET/CT helps detect pancreatic neuroendocrine tumors

By Wayne Forrest

Monday, November 26 | 11:50 a.m.-12:00 p.m. | SSC13-09 | Room 505ABIn this retrospective study from University of Munich Hospital, researchers found that DOTATATE-PET/CT detects pancreatic neuroendocrine tumors better than MRI.

November 7, 2012

Microbubble US helps early assessment of liver dysplasia

By Wayne Forrest

Monday, November 26 | 11:30 a.m.-11:40 a.m. | SSC09-07 | Room S504CDIn this presentation, German researchers will discuss their preliminary success with an ultrasound contrast agent -- known as BR55 -- that uses microbubbles targeting vascular endothelial growth factor receptor 2 to assess liver dysplasia.

November 7, 2012

PET/MRI outshines PET/CT in lesion detection

By Wayne Forrest

Monday, November 26 | 11:00 a.m.-11:10 a.m. | SSC13-04 | Room S505ABPET/MRI showed superior lesion detectability compared to contrast-enhanced PET/CT in this study from King Fahad Specialist Hospital in Dammam, Saudi Arabia. Based on the results, researchers concluded that PET/MRI may be useful for abdominal lesion staging while sparing patients from contrast media.

November 7, 2012

NaF-PET/CT detects more skeletal lesions in advanced breast cancer cases

By Wayne Forrest

Monday, November 26 | 11:00 a.m.-11:10 a.m. | SSC09-04 | Room S504CDF-18 sodium fluoride (NaF) PET/CT detects more skeletal lesions than technetium-99m methylene diphosphonate SPECT in patients newly diagnosed with breast cancer, according to researchers from India.

November 7, 2012

FDG-PET/CT predicts response to chemo in breast cancer patients

By Wayne Forrest

Sunday, November 25 | 11:55 a.m.-12:05 p.m. | SSA18-08 | Room S505ABIn this presentation, Japanese researchers will discuss the ability of FDG tumor uptake at baseline and after neoadjuvant chemotherapy to predict pathological complete response and disease-free survival after surgery.

November 7, 2012

Page 286 of 615